Clinical Policy Title: Outpatient diabetes self-management training (DSMT)

Size: px
Start display at page:

Download "Clinical Policy Title: Outpatient diabetes self-management training (DSMT)"

Transcription

1 Clinical Policy Title: Outpatient diabetes self-management training (DSMT) Clinical Policy Number: Effective Date: July 1, 2013 Initial Review Date: April 23, 2013 Most Recent Review Date: March 15, 2017 Next Review Date: March 2018 Policy contains: Outpatient diabetes selfmanagement (DSMT). Certificate of Recognition. Diabetes mellitus. Related policies: CP# CP# CP# Artificial pancreas device system Continuous interstitial glucose monitors (CGMS) Insulin infusion therapy (insulin pumps) ABOUT THIS POLICY: Keystone First has developed clinical policies to assist with making coverage determinations. Keystone First s clinical policies are based on guidelines from established industry sources, such as the Centers for Medicare & Medicaid Services (CMS), state regulatory agencies, the American Medical Association (AMA), medical specialty professional societies, and peer-reviewed professional literature. These clinical policies along with other sources, such as plan benefits and state and federal laws and regulatory requirements, including any state- or plan-specific definition of medically necessary, and the specific facts of the particular situation are considered by Keystone First when making coverage determinations. In the event of conflict between this clinical policy and plan benefits and/or state or federal laws and/or regulatory requirements, the plan benefits and/or state and federal laws and/or regulatory requirements shall control. Keystone First s clinical policies are for informational purposes only and not intended as medical advice or to direct treatment. Physicians and other health care providers are solely responsible for the treatment decisions for their patients. Keystone First s clinical policies are reflective of evidence-based medicine at the time of review. As medical science evolves, Keystone First will update its clinical policies as necessary. Keystone First s clinical policies are not guarantees of payment. Coverage policy Keystone First considers the use of outpatient diabetes self-management and training (DSMT) to be clinically proven and, therefore, medically necessary when ordered by a qualified health care professional and when the following criteria are met: Patient eligibility criteria (must meet at least one of criterion A, B, C, or D) A. The individual is newly diagnosed with diabetes mellitus by means of one of the following: A fasting blood sugar greater than or equal to 126 mg/dl on two different occasions. A two-hour post-glucose challenge 200 mg/dl. A random glucose test > 200 mg/dl for an individual with symptoms of uncontrolled diabetes. An HbA1C level 6.5 percent. B. The individual diagnosed with diabetes exhibits poor glycemic control evidenced by a glycosylated 1

2 Patient eligibility criteria (must meet at least one of criterion A, B, C, or D) hemoglobin (HbA1C) 9.5 percent in the 90 days before attending the DSMT. C. The treating professional health care provider detects that the individual diagnosed with diabetes requires a change in the treatment regimen where re-education or refresher training is necessary (e.g., from no diabetes medication to any diabetes medication, or from oral diabetes medication to insulin). D. The treating professional health care provider detects that the individual with diagnosed diabetes is deemed to be at high risk based on either: Evidence of poor glycemic control, with documentation of acute episodes of severe hypoglycemia, or acute severe hyperglycemia within the past year that required third-party assistance for either emergency room visits or hospitalization. Documented complications including, but not limited to, one of the following: - An absence of feeling in the foot or other foot complications (e.g., foot ulcer, amputation). - Pre-proliferative or proliferative retinopathy, or prior laser treatment of the eye. - Renal complications related to diabetes (e.g., macroalbuminuria, elevated creatinine). and DSMT program criteria (criteria A, B, C, D, and E must be met) A. Assessment of the diabetic individual s specific education needs, including all of the following: Family involvement, social support, and community resources. Nutrition and meal planning, skin care, exercise, and physical activity needs. Use of medications, safety and effectiveness, and an insulin treatment plan developed specifically for the individual, where applicable. Prevention, detection, and treatment of acute and chronic complications. B. Identification of the individual s specific diabetes self-management goals. C. Behavioral intervention and education to help the individual achieve his or her identified diabetes selfmanagement goal, including: Instruction in blood glucose self-monitoring. Motivation for the individual to use the skills acquired with DSMT. D. Ongoing evaluation of the individual s actualization of his or her identified diabetic self-management goals. E. The DSMT includes a comprehensive plan of care that describes the content, number, frequency, and duration of the DSMT as applied to either of the following: Services furnished in a group setting of two to 20 individuals. The need for individual DSMT sessions is justified by one of the following: - Group sessions are unavailable within two months of the date the training is ordered. - The physician or professional health care provider orders additional insulin education. - The individual is unable to participate in a group setting due to, but not limited to, one of the following: Severe vision, hearing, or language limitations. Special conditions identified by the treating physician or professional health care provider. Limitations: 2

3 All other uses of DSMT are not medically necessary. An initial 10 hours of DSMT within a continuous 12-month period is medically necessary for a member diagnosed with diabetes. A maximum of two hours of DSMT each year is medically necessary for a member with diabetes, beginning with the calendar year in which the recipient received their initial training. The need for DSMT and program plan must be maintained and documented in the member s medical record. Included are statements regarding the number of hours, topics covered, and the member s need for individual or group training. DSMT is not medically necessary for a member who is a patient in a hospital, skilled nursing facility, hospice, or nursing home. DSMT in the home setting is an integral part of a home visit; as such it is not eligible for separate reimbursement. The health care provider maintains a certificate of recognition from the American Diabetes Association (ADA), American Association of Diabetes Educators (AADE), or other Centers for Medicare & Medicaid Services (CMS)-acknowledged certification entity that affirms recognized provider status for the diabetes educator and education program. Alternative covered services: Diabetes self-management education as part of an inpatient occurrence. Diabetes self-management education as an integral part of a home visit. Background Diabetes mellitus is a chronic endocrine disease that involves a detrimental change in the secretion of insulin from the pancreas marked by high levels of blood glucose resulting from defects in insulin production, insulin action, or both. Diabetes mellitus is classified as type 1 (destruction of insulin-producing pancreatic beta-cells) and type 2 (gradual loss of the ability to produce insulin). The risk of diagnosed diabetes is highest among those of Asian, Hispanic, and non-hispanic black descent (Centers for Disease Control and Prevention [CDC] 2014). Prediabetes is a condition in which the blood glucose levels are higher than normal, but are not yet high enough to be diagnosed as type 2 diabetes (T2DM). Interventions such as diet and exercise can correct prediabetes and prevent or delay T2DM. Diabetes and prediabetes may affect anyone at any time during his or her life span (CDC 2014). DSMT: Diabetes requires long-term medical management to limit the extent of complications associated with the disease. DSMT is an ongoing, collaborative process in which diabetes educators help diabetic individuals gain the knowledge, coping, problem-solving, decision making, and self-behavior skills needed to 3

4 successfully manage the disease and its associated comorbidities (Minet 2010). DSMT integrates functional, medical, cultural, psychosocial, and spiritual goals of care. The degree to which individuals are able to learn, process, and understand health information is a factor of their health literacy. Successful diabetes selfmanagement entails active participation in a large amount of tasks of varying complexity that integrate learned behaviors into the context of daily life (Wallace 2010). Searches Keystone First searched PubMed and the databases of: UK National Health Services Centre for Reviews and Dissemination. Agency for Healthcare Research and Quality s (AHRQ s) National Guideline Clearinghouse and other evidence-based practice centers. CMS. We conducted searches on January 18, Search terms were: "diabetes self-management," "diabetes mellitus/education" (MeSH), "diabetes mellitus/organization and administration" (MeSH), and "diabetes mellitus/prevention and control" (MeSH). We included: Systematic reviews, which pool results from multiple studies to achieve larger sample sizes and greater precision of effect estimation than in smaller primary studies. Systematic reviews use predetermined transparent methods to minimize bias, effectively treating the review as a scientific endeavor, and are thus rated highest in evidence-grading hierarchies. Guidelines based on systematic reviews. Economic analyses, such as cost-effectiveness, and benefit or utility studies (but not simple cost studies), reporting both costs and outcomes sometimes referred to as efficiency studies which also rank near the top of evidence hierarchies. Findings Evidence from systematic reviews shows that DSMT can significantly improve glycemic control, diabetes knowledge, self-management skills, and self-efficacy and empowerment (Steinsbekk 2012; Duke 2009; Couch 2008; Deakin 2005). DSMT and education are considered integral parts of diabetic care, and medical treatment without these components is considered inadequate (American Diabetes Association [ADA] 2014; Haas 2014). The ADA and the American Association of Diabetes Educators place the diabetic individual s condition, desires, abilities, and tolerances at the center of the decision-making process (Haas 2014). Typically, a certified diabetes educator performs a one-hour assessment to develop an appropriate education program tailored to the individual s specific needs. Group sessions are usually two hours in length, while individual diabetes education may use one hour sessions to address individual requirements. Evidence based standards guide instructions for nutrition (diet) and exercise, self-monitoring of blood 4

5 glucose, and the inclusion of an insulin treatment plan (for each individual who is insulin-dependent) or oral medication (for those on oral therapy). Presently, higher-intensity face-to-face interventions (group or one-to-one) set the current standard for DSMT. Computer-based, cellular phone, and web-based interventions are readily available tools that could improve health outcomes in diabetes care by facilitating intense patient self-management. For these interventions to improve outcomes, they must help patients improve their knowledge and understanding of diabetes and change their patterns of eating, physical activity, and adherence to treatment regimens. Their value has been demonstrated in other areas of chronic disease self-management. Policy updates: Two systematic reviews examined the role of information communication technology in facilitating diabetes self-management and improving patient outcomes (Pal, 2013; Hayes, 2014). The evidence from these systematic reviews is based on multiple randomized controlled trials (RCTs) of low to moderate quality with variable intervention protocols and reporting of study details that make the risk of bias difficult to determine in most cases. These systematic reviews found: Sufficient evidence to show that computer-based, cellular phone, and web-based interventions are safe interventions with minimal to no adverse effects reported. Insufficient evidence to support the routine use of computer-based, cellular phone, and webbased interventions in DSMT. There is low- to moderate-quality evidence of effectiveness showing that mobile phones and two-way communication with frequent feedback improve HbA1C and adherence to self-management regimens in adults in the short term, but evidence in children and adolescents is limited with inconsistent results. Insufficient evidence to support either the clinical relevance of these intermediate outcomes on health outcomes or the cost-effectiveness of these interventions compared to the current standards of care. A meta-analysis summarized the results of 62 studies, representing 67 RCTs, of the effect of consumer health information technologies on outcomes in DSMT (Or 2014). The use of these technologies was associated with significant reductions in HbA1C, blood pressure, total cholesterol, and triglycerides levels when compared with the usual care. However, only a small proportion of the trials reported positive effects on patient outcomes. The effectiveness of the technologies in improving patient outcomes still awaits confirmation in future studies. A comprehensive systematic review of 120 RCTs comprising more than 22,000 total participants and 118 unique interventions found robust data demonstrating that engagement in DSMT results in a statistically significant decrease in HbA1C levels (Chrval 2016). Combination DSMT resulted in the largest decreases in HbA1C (0.88) compared with only group, individual, and remote interventions. The magnitude of reductions in HbA1C in participants exposed to DSMT exceeded that of usual care by more than 0.5 percent for all modes of delivery other than primarily remote. However, only 12 studies offered remote interventions, and the results should be interpreted cautiously. More than 10 contact hours were 5

6 associated with a greater proportion of interventions with significant reduction in HbA1C (70.3 percent). In patients with persistently elevated glycemic values (HbA1C > 9), a greater proportion of studies reported statistically significant reduction in HbA1C (83.9 percent). The data suggest mode of delivery, hours of engagement, and baseline HbA1C can affect the likelihood of achieving statistically significant and clinically meaningful improvement in HbA1C. People with severe mental illness are at higher risk of developing T2DM. It is not clear if existing treatment guidelines for T2DM are generalizable to those with severe mental illness. One new Cochrane review found insufficient evidence from one low-quality RCT to determine if a tailored approach to diabetes education was more effective than usual diabetes care plus information in this population (McBain, 2016). These results do not change previous conclusions. Therefore no policy changes are warranted. Summary of clinical evidence: Citation Chrvala (2016) DSMT and support methods, providers, duration, and contact time on glycemic control in adults with T2DM McBain (2016) Cochrane review DSMT tailored for people with T2DM and severe mental illness Hayes (2014) Content, Methods, Recommendations Key points: Systematic review of 120 RCTs (11,854 participants in intervention group, 11,093 participants in control group) and 118 unique interventions. Overall quality: low with high risk of bias. Overall mean reduction in HbA1C was 0.74 and 0.17 for intervention and control groups, respectively; an average absolute reduction in HbA1C of Combination DSMT resulted in the largest decreases in HbA1C (0.88) compared with group, individual, and remote interventions. Contact hours > 10 were associated with a greater proportion of interventions with significant reduction in HbA1C (70.3%). In patients with persistently elevated glycemic values (HbA1C > 9), a greater proportion of studies reported statistically significant reduction in HbA1C (83.9%). No differences in the mean change in HbA1C between single or team DSMT providers. DSME > 10 hours was associated with a slightly higher overall mean reduction in HbA1C. Key points: Systematic review of one RCT (three publications; 64 total participants with schizophrenia or schizoaffective disorder) comparing a 24-week Diabetes Awareness and Rehabilitation Training program to usual care plus information. Overall quality: unclear risk of bias. No significant improvement in total energy expenditure, HbA1C at six or 12 months of follow-up, or blood pressure. Anecdotal small improvements in body mass index, weight, diabetes knowledge, and self-efficacy immediately post-intervention, and knowledge also at six months. Key points: Information communication technology (ICT, cellular phones with short message service Systematic review of 18 RCTs (sample sizes: 30 to 463 patients). Overall quality: low to moderate. ICT improves HbA1C and adherence to self-management regimens in adults, but evidence in children and adolescents is limited with inconsistent results. ICT with two-way communication with frequent feedback is most effective. 6

7 Citation and web-based services) in DSMT Pal (2013) Content, Methods, Recommendations The use of ICT is safe with no reported side effects. Key points: Cochrane review Computer-based DSMT on health status and health-related quality of life (HRQOL) in adults with T2DM Systematic review of 16 RCTs (3,578 total patients). Overall quality: unclear risk of bias. No blinding, heterogeneous interventions, incomplete reporting of critical study design details. Age of participants was years, mean time since diagnosis was six 13 years. The duration of the interventions one to 12 months. Three reported deaths. Computer-based DSMT has limited effectiveness: small benefits on glycemic control (pooled effect on HbA1C: -2.3 mmol/mol or -0.2% (95% confidence interval [CI] -0.4 to -0.1; P = 0.009; 2,637 participants; 11 trials). The effect size on HbA1C was larger in the mobile phone subgroup (mean difference in HbA1C -5.5 mmol/mol or -0.5% [95% CI -0.7 to -0.3]; P < ; 280 participants; three RCTs). Current interventions do not show adequate evidence for improving depression, HRQOL, weight, or other outcomes. No documented adverse effects. Two studies provided limited cost-effectiveness data one study found costs per patient of less than $140 (in 1997) and another showed no change in health behavior and resource utilization. References Professional society guidelines/other: Funnell MM, Brown TL, Childs BP, et al. National Standards for Diabetes Self-Management Education. Diabetes Care. 2011; 34(Suppl 1): S89 - S96. Haas L, Maryniuk M, Beck J, et al. National standards for diabetes self-management education and support. Diabetes Care. 2014; 37 Suppl 1: S144 - S153. Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011; 17 Suppl 2: Standards of Medical Care in Diabetes-2016: Summary of Revisions. Diabetes Care. 2016; 39 Suppl 1: S4-5. American Diabetes Association (ADA) website. Accessed March 7, Peer-reviewed references: Couch R, Jetha M, Dryden DM, et al. Diabetes Education for Children With Type 1 Diabetes Mellitus and Their Families. Evidence Report/Technology Assessment No (Prepared by the University of Alberta/Capital Health Evidence-based Practice Center under Contract No ) AHRQ Publication 7

8 No. 08-E011. April Rockville, MD. AHRQ website. Accessed January 18, Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns. 2016; 99(6): Deakin T, McShane CE, Cade JE, Williams RD. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005; (2): Cd Duke SA, Colagiuri S, Colagiuri R. Individual patient education for people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2009; (1): Cd Hayes, Inc. Hayes Medical Directory Report. The Use of Information Communication Technology (ICT) to Improve Treatment Adherence in Patients with Diabetes. Lansdale, Pa. Hayes, Inc.; March Minet L, Moller S, Vach W, Wagner L, Henriksen JE. Mediating the effect of self-care management intervention in type 2 diabetes: a meta-analysis of 47 randomized controlled trials. Patient Educ Couns 2010, 80: National Diabetes Statistics Report, CDC website. Accessed January 18, National Diabetes Education Program. National Institute of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases website. Accessed January 18, Pal K, Eastwood SV, Michie S, et al. Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2013; 3: Cd Steinsbekk A, Rygg LO, Lisulo M, Rise MB, Fretheim A. Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with metaanalysis. BMC Health Serv Res. 2012; 12: 213. Wallace, A. Low Health Literacy: Overview, Assessment, and steps toward providing high-quality diabetes care. Diabetes Spectrum. 2010; 23(4): CMS National Coverage Determinations (NCDs): NCD for Diabetes Outpatient Self-Management Training (40.1). CMS website. January 18, Transmittal 1255, Change 5433, May 25, CMS website. Guidance/Guidance/Transmittals/downloads/R1255CP.pdf. Accessed January 18,

9 CMS Coverage Issues Manual. Part 80: Patient education programs. 80-2: Outpatient diabetic education programs. September CMS website. Guidance/Guidance/Transmittals/downloads/R141CIM.pdf. Accessed January 18, Medicare Program; Expanded Coverage for Outpatient Diabetes Self-Management Training and Diabetes Outcome Measurements; Final Action. December 29, Federal Register website. Accessed January 18, Local Coverage Determinations (LCDs): No LCDs identified as of the writing of this policy. Commonly submitted codes Below are the most commonly submitted codes for the service(s)/item(s) subject to this policy. This is not an exhaustive list of codes. Providers are expected to consult the appropriate coding manuals and bill in accordance with those manuals. CPT Code Description Comment Medical nutrition therapy; initial assessment and intervention, individual, face-toface with the patient, each 15 minutes Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes Medical nutrition therapy, group (2 or more individual (s)), each 30 minutes Education and training for patient self-management by a qualified, non-physician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; individual patient Education and training for patient self-management by a qualified, non-physician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; 2-4 patients Education and training for patient self-management by a qualified, non-physician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; 5-8 patients Physician or other qualified health care professional qualified by education, training, licensure/regulation (when applicable) educational services rendered to patients in a group setting (eg prenatal, obesity, or diabetic instructions) ICD-10 Code Description Comment E08.xx E09.xx E10.xx E11.xx E13.xx Diabetes mellitus due to underlying condition Drug or chemical induced diabetes mellitus Type 1 diabetes mellitus Type 2 diabetes mellitus Other specified diabetes mellitus 9

10 O24.xx Diabetes mellitus in pregnancy, childbirth, and the puerperium O99.81x Abnormal glucose complicating pregnancy, childbirth and the puerperium Z79.4 Long term (current) use of Insulin HCPCS Level II Code Description Comment G0108 Diabetes outpatient self-management training services (DSMT); individual session, face-to-face with the pt, each 30 minutes of training G0109 Diabetes outpatient self-management training services (DSMT), group session (2 or more), face-to-face with the pts, each 30 minutes of training per 30 minutes S9140 Diabetic management program, follow-up visit to non-md provider Not covered by S9141 Diabetic management program, follow-up visit to MD provider Not covered by S9455 Diabetic management program, group session Not covered by S9460 Diabetic management program, nurse visit Not covered by S9465 Diabetic management program, dietitian visit Not covered by 10

Clinical Policy Title: Cardiac rehabilitation

Clinical Policy Title: Cardiac rehabilitation Clinical Policy Title: Cardiac rehabilitation Clinical Policy Number: 04.02.02 Effective Date: September 1, 2013 Initial Review Date: February 19, 2013 Most Recent Review Date: February 6, 2018 Next Review

More information

LOUISIANA MEDICAID PROGRAM ISSUED: 02/01/12 REPLACED: 02/01/94 CHAPTER 5: PROFESSIONAL SERVICES SECTION 5.1: COVERED SERVICES PAGE(S) 6

LOUISIANA MEDICAID PROGRAM ISSUED: 02/01/12 REPLACED: 02/01/94 CHAPTER 5: PROFESSIONAL SERVICES SECTION 5.1: COVERED SERVICES PAGE(S) 6 Diabetes Education Management Training Diabetes self management training (DSMT) is a collaborative process through which recipients with diabetes gain knowledge and skills needed to modify behavior and

More information

Cigna Medical Coverage Policy

Cigna Medical Coverage Policy Cigna Medical Coverage Policy Subject Diabetes Self-Management Education Table of Contents Coverage Policy... 1 General Background... 1 Coding/Billing Information... 3 References... 4 Effective Date...

More information

Clinical Policy Title: Strep testing

Clinical Policy Title: Strep testing Clinical Policy Title: Strep testing Clinical Policy Number: 07.01.09 Effective Date: December 1, 2017 Initial Review Date: October 19, 2017 Most Recent Review Date: November 16, 2017 Next Review Date:

More information

8/12/2016. Outline. New CPT Code for Pre-Diabetes Education. Medicare Proposed Coverage for DPP. Medicare Proposed Coverage for DPP cont.

8/12/2016. Outline. New CPT Code for Pre-Diabetes Education. Medicare Proposed Coverage for DPP. Medicare Proposed Coverage for DPP cont. New CPT Code for Pre-Diabetes Education 0403T: Preventive behavior change, intensive program of prevention of diabetes using a standardized diabetes prevention program curriculum, provided to individuals

More information

Clinical Policy Title: Ketamine for treatment-resistant depression

Clinical Policy Title: Ketamine for treatment-resistant depression Clinical Policy Title: Ketamine for treatment-resistant depression Clinical Policy Number: 00.02.13 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: January

More information

Clinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering)

Clinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering) Clinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering) Clinical Policy Number: 17.02.02 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent

More information

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Number: 05.01.03 Effective Date: January 1, 2016 Initial Review Date: July 15, 2015 Most Recent Review Date:

More information

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Number: 01.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21, 2015 Most Recent

More information

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Number: 05.01.03 Effective Date: January 1, 2016 Initial Review Date: July 15, 2015 Most Recent Review Date:

More information

Clinical Policy Title: Genicular nerve block

Clinical Policy Title: Genicular nerve block Clinical Policy Title: Genicular nerve block Clinical Policy Number: 14.01.10 Effective Date: October 1, 2017 Initial Review Date: September 21, 2017 Most Recent Review Date: October 19, 2017 Next Review

More information

Clinical Policy Title: Zoster (shingles) vaccine

Clinical Policy Title: Zoster (shingles) vaccine Clinical Policy Title: Zoster (shingles) vaccine Clinical Policy Number: 18.02.10 Effective Date: June 1, 2018 Initial Review Date: April 10, 2018 Most Recent Review Date: May 1, 2018 Next Review Date:

More information

Continuous Glucose Monitoring System

Continuous Glucose Monitoring System Continuous Glucose Monitoring System Policy Number: Original Effective Date: MM.02.003 03/13/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 4/1/2018 Section: DME Place(s)

More information

Continuous Glucose Monitoring System

Continuous Glucose Monitoring System Continuous Glucose Monitoring System Policy Number: Original Effective Date: MM.02.003 03/13/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2016 Section: DME Place(s)

More information

Clinical Policy Title: Vacuum assisted closure in surgical wounds

Clinical Policy Title: Vacuum assisted closure in surgical wounds Clinical Policy Title: Vacuum assisted closure in surgical wounds Clinical Policy Number: 17.03.00 Effective Date: September 1, 2015 Initial Review Date: June 16, 2013 Most Recent Review Date: August 17,

More information

Continuous Glucose Monitoring System

Continuous Glucose Monitoring System Continuous Glucose Monitoring System Policy Number: Original Effective Date: MM.02.003 03/13/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2017 Section: DME Place(s)

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Continuous Monitoring of Glucose in the Interstitial Fluid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: continuous_monitoring_of_glucose_in_the_interstitial_fluid

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Insulin Therapy, Chronic Intermittent Intravenous (CIIIT) File Name: Origination: Last CAP Review: Next CAP Review: Last Review: insulin_therapy_chronic_intermittent_intravenous

More information

Clinical Policy Title: Abdominal aortic aneurysm screening

Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: July 20, 2017 Next

More information

Insulin Pumps - External

Insulin Pumps - External Insulin Pumps - External Policy Number: Original Effective Date: MM.01.004 04/01/2011 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/20174/1/2018 Section: DME Place(s) of

More information

Clinical Policy Title: Abdominal aortic aneurysm screening

Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next

More information

Clinical Policy Title: Artificial pancreas device system

Clinical Policy Title: Artificial pancreas device system Clinical Policy Title: Artificial pancreas device system Clinical Policy Number: 08.02.07 Effective Date: April 1, 2016 Initial Review Date: November 18, 2015 Most Recent Review Date: February 6, 2018

More information

Clinical Policy Title: Abdominal aortic aneurysm screening

Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next

More information

Clinical Policy Title: Continuous interstitial glucose monitoring (CGM)

Clinical Policy Title: Continuous interstitial glucose monitoring (CGM) Clinical Policy Title: Continuous interstitial glucose monitoring (CGM) Clinical Policy Number: 06.02.03 Effective Date: September 1, 2013 Initial Review Date: April 23, 2013 Most Recent Review Date: April

More information

Mary Ann Hodorowicz RDN, MBA, CDE, CEC (Certified

Mary Ann Hodorowicz RDN, MBA, CDE, CEC (Certified Mary Ann Hodorowicz RDN, MBA, CDE, CEC (Certified Endocrinology Coder) Mary Ann Hodorowicz, RDN, MBA, CDE, CEC, is a licensed registered dietitian and certified diabetes educator and earned her MBA with

More information

If DSME* were a pill, would you prescribe it?

If DSME* were a pill, would you prescribe it? If DSME* were a pill, would you prescribe it? *Diabetes Self-Management Education/Training Jan Kincaid Rystrom, RD CDE MEd Manager, Diabetes Education EvergreenHealth Goals Evaluate DSME as part of ADA

More information

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Outline of Material Introduction

More information

Clinical Policy Title: Continuous interstitial glucose monitoring (CGM)

Clinical Policy Title: Continuous interstitial glucose monitoring (CGM) Clinical Policy Title: Continuous interstitial glucose monitoring (CGM) Clinical Policy Number: 06.02.03 Effective Date: September 1, 2013 Initial Review Date: April 23, 2013 Most Recent Review Date: June

More information

Diabetes Self-Management Education and Support Joint Position Statement

Diabetes Self-Management Education and Support Joint Position Statement Diabetes Self-Management Education and Support Joint Position Statement User Guide This guide is meant to assist diabetes educators with implementing the recommendations from the Diabetes Self-Management

More information

Clinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab

Clinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab Clinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab Clinical Policy Number: 01.01.03 Effective Date: January 1, 2016 Initial Review Date: September 16, 2015 Most Recent

More information

Contractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC B. LCD ID Number: L34834 Status: A-Approved

Contractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC B. LCD ID Number: L34834 Status: A-Approved LCD for Blood Glucose Monitoring in a Skilled Nursing Facility (SNF) (L34834) Contractor Name: Novitas Solutions, Inc. Contractor Number: 12502 Contractor Type: MAC B LCD ID Number: L34834 Status: A-Approved

More information

Clinical Policy Title: Breast cancer index genetic testing

Clinical Policy Title: Breast cancer index genetic testing Clinical Policy Title: Breast cancer index genetic testing Clinical Policy Number: 02.01.22 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19, 2016

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association.

Medical Policy An independent licensee of the Blue Cross Blue Shield Association. Insulin Pump Page 1 of 12 Medical Policy An independent licensee of the Blue Cross Blue Shield Association. Title: Insulin Pump Professional Original Effective Date: January 1, 1999 Revision Date(s): June

More information

REVIEW AND FREQUENTLY ASKED QUESTIONS (FAQ) 8/5/2015. Outline. Navigating the DSMT Reimbursement Maze in Todays Changing Environment

REVIEW AND FREQUENTLY ASKED QUESTIONS (FAQ) 8/5/2015. Outline. Navigating the DSMT Reimbursement Maze in Todays Changing Environment Patty Telgener RN, MBA, CPC VP of Reimbursement Emerson Consultants Navigating the DSMT Reimbursement Maze in Todays Changing Environment Patty Telgener, RN, MBA, CPC VP of Reimbursement Emerson Consultants

More information

Clinical Policy Title: Applied behavior analysis (ABA)

Clinical Policy Title: Applied behavior analysis (ABA) Clinical Policy Title: Applied behavior analysis (ABA) Clinical Policy Number: 11.04.03 Effective Date: October 1, 2015 Initial Review Date: May 15, 2015 Most Recent Review Date: June 15, 2016 Next Review

More information

Diabetes Self-Management Education and Support (DSMES) Accreditation/Recognition 101

Diabetes Self-Management Education and Support (DSMES) Accreditation/Recognition 101 Diabetes Self-Management Education and Support (DSMES) Accreditation/Recognition 101 What is DSMES? Diabetes Self-Management Education and Support (DSMES) Evidence-based intervention that strengthens the

More information

Gerald Bernstein, MD, Director, Diabetes Management Program. Marina Krymskaya, RN, MSN, ANP, CDE FDI Assistant Director

Gerald Bernstein, MD, Director, Diabetes Management Program. Marina Krymskaya, RN, MSN, ANP, CDE FDI Assistant Director Gerald Bernstein, MD, Director, Diabetes Management Program Marina Krymskaya, RN, MSN, ANP, CDE FDI Assistant Director November, 2010 1 Epidemiology CDC: 1 of 3 born in 2000 will develop diabetes. 42.3%

More information

8/13/2016. A Joint DSME/S Position Statement One Year Later. DSME/S Position Statement: Collaboration. Definitions. ADA Standards of Medical Care

8/13/2016. A Joint DSME/S Position Statement One Year Later. DSME/S Position Statement: Collaboration. Definitions. ADA Standards of Medical Care DSME/S Position Statement: Collaboration Writing team represented 4 organizations Other organizations and disciplines provided input and review Maggie Powers (Chair), ADA Joan Bardsley, AADE Marjorie Cypress,

More information

Clinical Policy Title: Computerized gait analysis

Clinical Policy Title: Computerized gait analysis Clinical Policy Title: Computerized gait analysis Clinical Policy Number: 15.01.01 Effective Date: October 1, 2014 Initial Review Date: May 21, 2014 Most Recent Review Date: May 1, 2018 Next Review Date:

More information

Clinical Policy Title: Ear tubes (tympanostomy)

Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Number: 11.03.05 Effective Date: January 1, 2015 Initial Review Date: September 17, 2014 Most Recent Review Date: September 21, 2017 Next

More information

Clinical Policy Title: Room humidifiers

Clinical Policy Title: Room humidifiers Clinical Policy Title: Room humidifiers Clinical Policy Number: 17.02.05 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2016 Next Review Date:

More information

Clinical Policy Title: Computerized gait analysis

Clinical Policy Title: Computerized gait analysis Clinical Policy Title: Computerized gait analysis Clinical Policy Number: 15.01.01 Effective Date: October 1, 2014 Initial Review Date: May 21, 2014 Most Recent Review Date: June 22, 2017 Next Review Date:

More information

Medicare s Current Diabetes Self-Management Training (DSMT) Coverage and Proposed Diabetes Prevention Program (DPP) Rule

Medicare s Current Diabetes Self-Management Training (DSMT) Coverage and Proposed Diabetes Prevention Program (DPP) Rule Medicare s Current Diabetes Self-Management Training (DSMT) Coverage and Proposed Diabetes Prevention Program (DPP) Rule Karen Ten Cate, MA, RD, CDE Friday, March 10, 2017 Diabetes Self-Management Training

More information

13 B: Colorado Diabetes Burden Map. 15 References 15

13 B: Colorado Diabetes Burden Map. 15 References 15 Definitions 2 Purpose of Toolkit 2 Diabetes Self-Management Education (DSME) 3 Medicaid DSME Benefit Overview 4 Eligibility 4 Diagnostic Criteria 4 Accreditation 5 Components of a Qualified DSME Program

More information

= AUDIO. Managing Diabetes for Improved Cardiovascular Health. An Important Reminder. Mission of OFMQ 8/18/2015. Jimmi Norris MS, RN, CDE

= AUDIO. Managing Diabetes for Improved Cardiovascular Health. An Important Reminder. Mission of OFMQ 8/18/2015. Jimmi Norris MS, RN, CDE Managing Diabetes for Improved Cardiovascular Health Jimmi Norris MS, RN, CDE An Important Reminder For audio, you must use your phone: Step 1: Call (866) 906 0123. Step 2: Enter code 2071585#. Step 3:

More information

Continuous Glucose Monitoring (CGM)

Continuous Glucose Monitoring (CGM) Continuous Glucose Monitoring (CGM) Date of Origin: 02/2001 Last Review Date: 07/26/2017 Effective Date: 07/26/2017 Dates Reviewed: 04/2004, 04/2005, 03/2006, 11/2006, 12/2007, 03/2008, 09/2008, 04/2009,

More information

What s App? Challenges and Opportunities in Diabetes Mobile Technologies

What s App? Challenges and Opportunities in Diabetes Mobile Technologies Disclosure Information What s App? Challenges and Opportunities in Diabetes Mobile Technologies I have no conflicts of interest to disclose. Addie L. Fortmann, PhD Scripps Whittier Diabetes Institute,

More information

Continuous Glucose Monitoring (CGM)

Continuous Glucose Monitoring (CGM) Continuous Glucose Monitoring (CGM) Date of Origin: 02/2001 Last Review Date: 08/22/2018 Effective Date: 08/22/2018 Dates Reviewed: 04/2004, 04/2005, 03/2006, 11/2006, 12/2007, 03/2008, 09/2008, 04/2009,

More information

Diabetes Education Columbus Community Hospital Stacy Biesel RN, CDE

Diabetes Education Columbus Community Hospital Stacy Biesel RN, CDE Diabetes Education Columbus Community Hospital Stacy Biesel RN, CDE Stacy Biesel, RN CDE Registered Nurse Certified Diabetes Educator Locations: Columbus Community Hospital Prairie Ridge Health Clinic

More information

Clinical Policy Title: Platelet rich plasma

Clinical Policy Title: Platelet rich plasma Clinical Policy Title: Platelet rich plasma Clinical Policy Number: 05.02.10 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2017 Next Review

More information

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Number: 09.01.02 Effective Date: September 1, 2013 Initial Review Date: February 18, 2013 Most

More information

An Overview of Medicare Covered Diabetes Supplies and Services

An Overview of Medicare Covered Diabetes Supplies and Services News Flash - Understanding the Remittance Advice: A Guide for Medicare Providers, Physicians, Suppliers, and Billers serves as a resource on how to read and understand a Remittance Advice (RA). Inside

More information

Clinical Policy: Mifepristone (Korlym) Reference Number: CP.PHAR.101

Clinical Policy: Mifepristone (Korlym) Reference Number: CP.PHAR.101 Clinical Policy: (Korlym) Reference Number: CP.PHAR.101 Effective Date: 05/12 Last Review Date: 04/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory

More information

Clinical Policy Title: Platelet rich plasma

Clinical Policy Title: Platelet rich plasma Clinical Policy Title: Platelet rich plasma Clinical Policy Number: 05.02.10 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2016 Next Review

More information

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Number: 01.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21, 2015 Most Recent

More information

External Insulin Pumps Corporate Medical Policy

External Insulin Pumps Corporate Medical Policy File Name: External Insulin Pumps File Code: UM.DME.02 Origination: 04/2006 Last Review: 11/2018 Next Review: 11/2019 Effective Date: 04/01/2019 External Insulin Pumps Corporate Medical Policy Description/Summary

More information

Physical Activity/Exercise Prescription with Diabetes

Physical Activity/Exercise Prescription with Diabetes Physical Activity/Exercise Prescription with Diabetes B R AD H I NTERMEYER C E P A C SM S A NFORD H E ALTH C A RDIAC R E H AB A N D D I ABE TES E XE RCISE The adoption and maintenance of physical activity

More information

Chronic Intermittent Intravenous Insulin Therapy

Chronic Intermittent Intravenous Insulin Therapy 2.01.43 Chronic Intermittent Intravenous Insulin Therapy Section 2.0 Medicine Subsection Effective Date September 30, 2014 Original Policy Date February 14, 2001 Next Review Date September 2015 Description

More information

The Algorithm for DMSES Referrals: A toolkit made for Diabetes Educators to share critical referral times locally and nationally.

The Algorithm for DMSES Referrals: A toolkit made for Diabetes Educators to share critical referral times locally and nationally. The Algorithm for DMSES Referrals: A toolkit made for Diabetes Educators to share critical referral times locally and nationally. Joan Bardsley MBA, BS, RN, CDE, FAADE AVP Research and Nursing Integratio

More information

QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3?

QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3? 500 1 QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3? WHAT ADDITIONAL DATA ARE NEEDED? AACE/ACE CGM Consensus Conference:

More information

IABETES. Center for Diabetes Education* at Monmouth Medical Center

IABETES. Center for Diabetes Education* at Monmouth Medical Center M O N M O U T H M E D I C A L C E N T E R IABETES Center for Diabetes Education* at Monmouth Medical Center About the Center for Diabetes Education at Monmouth Medical Center According to the American

More information

National Diabetes Fact Sheet, 2011

National Diabetes Fact Sheet, 2011 National Diabetes Fact Sheet, 2011 FAST FACTS ON DIABETES Diabetes affects 25.8 million people 8.3% of the U.S. population DIAGNOSED 18.8 million people UNDIAGNOSED 7.0 million people All ages, 2010 Citation

More information

Clinical Policy Title: Applied behavior analysis

Clinical Policy Title: Applied behavior analysis Clinical Policy Title: Applied behavior analysis Clinical Policy Number: 11.04.03 Effective Date: October 1, 2015 Initial Review Date: May 15, 2015 Most Recent Review Date: May 1, 2018 Next Review Date:

More information

Coding spotlight: diabetes provider guide to coding the diagnosis and treatment of diabetes

Coding spotlight: diabetes provider guide to coding the diagnosis and treatment of diabetes Medicaid Managed Care December 2018 provider guide to coding the diagnosis and treatment of diabetes Diabetes mellitus is a chronic disorder caused by either an absolute decrease in the amount of insulin

More information

DIAGNOSIS OF DIABETES NOW WHAT?

DIAGNOSIS OF DIABETES NOW WHAT? DIAGNOSIS OF DIABETES NOW WHAT? DISCUSS GOALS FOR DIABETES CARE IDENTIFY COMMON COMPLIANCE- ADHERENCE ISSUES DESCRIBE TECHNOLOGY TO ASSIST AND / OR IMPROVE DIABETES CARE WHAT DO WE WANT OUR PATIENTS TO

More information

Provider Bulletin December 2018 Coding spotlight: diabetes provider guide to coding the diagnosis and treatment of diabetes

Provider Bulletin December 2018 Coding spotlight: diabetes provider guide to coding the diagnosis and treatment of diabetes Medi-Cal Managed Care L. A. Care Provider Bulletin December 2018 provider guide to coding the diagnosis and treatment of diabetes Diabetes mellitus is a chronic disorder caused by either an absolute decrease

More information

Clinical Policy Title: Statin use in adults and children

Clinical Policy Title: Statin use in adults and children Clinical Policy Title: Statin use in adults and children Clinical Policy Number: 04.02.09 Effective Date: May 1, 2016 Initial Review Date: February 17, 2016 Most Recent Review Date: September 21, 2017

More information

International Diabetes Center s Annual Symposium for Advanced Diabetes Educators: Discoveries in Diabetes: How They Will Change Your Practice

International Diabetes Center s Annual Symposium for Advanced Diabetes Educators: Discoveries in Diabetes: How They Will Change Your Practice International Diabetes Center s Annual Symposium for Advanced Diabetes Educators: Discoveries in Diabetes: How They Will Change Your Practice The Don Etzwiler Memorial Lecture: Critical Times for Diabetes

More information

DIABETES MEASURES GROUP OVERVIEW

DIABETES MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: DIABETES MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN DIABETES MEASURES GROUP: #1. Diabetes: Hemoglobin A1c Poor Control #2. Diabetes: Low Density Lipoprotein (LDL-C)

More information

Professional CGM Reimbursement Guide

Professional CGM Reimbursement Guide Professional CGM Reimbursement Guide 2015 TABLE OF CONTENTS Coding, Coverage and Payment...2 Coding and Billing...2 CPT Code 95250...3 CPT Code 95251...3 Incident to Billing for Physicians..............................................

More information

Clinical Policy Title: Discography

Clinical Policy Title: Discography Clinical Policy Title: Discography Clinical Policy Number: 03.01.01 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19, 2017 Next Review Date: October

More information

Can you see me now? Bringing DSME to rural S.C. via Telehealth. Mandy Floyd, RN Anita Longan, RDN, CDE, BC-ADM March 12, 2016

Can you see me now? Bringing DSME to rural S.C. via Telehealth. Mandy Floyd, RN Anita Longan, RDN, CDE, BC-ADM March 12, 2016 Can you see me now? Bringing DSME to rural S.C. via Telehealth Mandy Floyd, RN Anita Longan, RDN, CDE, BC-ADM March 12, 2016 HopeHealth A South Carolina Community Health Center What We Offer We served

More information

Clinical Policy Title: Pharmacogenomic tests for psychiatric medications

Clinical Policy Title: Pharmacogenomic tests for psychiatric medications Clinical Policy Title: Pharmacogenomic tests for psychiatric medications Clinical Policy Number: 02.02.01 Effective Date: October 1, 2015 Initial Review Date: April 15, 2015 Most Recent Review Date: May

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 57 Effective Health Care Program Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness Executive Summary Background Diabetes mellitus is

More information

Clinical Policy: Gastric Electrical Stimulation Reference Number: CP.MP.40

Clinical Policy: Gastric Electrical Stimulation Reference Number: CP.MP.40 Clinical Policy: Reference Number: CP.MP.40 Effective Date: 09/09 Last Review Date: 10/16 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and

More information

About the Highmark Foundation

About the Highmark Foundation About the Highmark Foundation The Highmark Foundation, created in 2000 as an affiliate of Highmark Inc., is a charitable organization and a private foundation that supports initiatives and programs aimed

More information

Diabetes Prevention in. Massachusetts: Prediabetes and the Diabetes Prevention Program. Diabetes Prevention and Control

Diabetes Prevention in. Massachusetts: Prediabetes and the Diabetes Prevention Program. Diabetes Prevention and Control Diabetes Prevention in r Massachusetts: Prediabetes and the Diabetes Prevention Program Diabetes Prevention and Control www.mass.gov/dph/diabetes Massachusetts Department of Public Health 29 million with

More information

Clinical Policy Title: Home phototherapy for hyperbilirubinemia

Clinical Policy Title: Home phototherapy for hyperbilirubinemia Clinical Policy Title: Home phototherapy for hyperbilirubinemia Clinical Policy Number: 11.02.04 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: August 17,

More information

TUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS

TUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS DIABETES MELLITUS 1. Introduction Diabetes is a global epidemic with 415 million people affected worldwide equivalent to the total population of the USA, Canada and Mexico. In recognition of this, the

More information

Diabetes Management, Equipment and Supplies

Diabetes Management, Equipment and Supplies Coverage Summary Diabetes Management, Equipment and Supplies Policy Number: D-001 Products: UnitedHealthcare Medicare Advantage Plans Original Approval Date: 11/01/2006 Approved by: UnitedHeatlhcare Medicare

More information

Comparative Effectiveness and Safety of Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus

Comparative Effectiveness and Safety of Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus Draft Comparative Effectiveness Review Number XX Comparative Effectiveness and Safety of Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus Prepared for: Agency for Healthcare Research

More information

National Diabetes Fact Sheet, 2007

National Diabetes Fact Sheet, 2007 National Diabetes Fact Sheet, 2007 General Information What is diabetes? Diabetes is a group of diseases marked by high levels of blood glucose resulting from defects in insulin production, insulin action,

More information

Clinical Policy Title: Investigational (experimental) health services

Clinical Policy Title: Investigational (experimental) health services Clinical Policy Title: Investigational (experimental) health services Clinical Policy Number: 18.04.03 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: September

More information

Continuous Glucose Monitoring Devices Pharmacy Policy

Continuous Glucose Monitoring Devices Pharmacy Policy Line of Business: All Line of Business Effective date: August 16, 2017 Revision date: August 16, 2017 Continuous Glucose Monitoring Devices Pharmacy Policy This policy has been developed through review

More information

Coverage Guidelines. Continuous Glucose Monitors (CGMs)

Coverage Guidelines. Continuous Glucose Monitors (CGMs) Coverage Guidelines Continuous Glucose Monitors (CGMs) Disclaimer: Please note that Baptist Health Plan Coverage Guidelines may be updated throughout the year. A printed version may not be most up to date

More information

TUEC Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS

TUEC Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS DIABETES MELLITUS 1. Introduction Diabetes is a global epidemic with 415 million people affected worldwide equivalent to the total population of the USA, Canada and Mexico. In recognition of this, the

More information

ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ

ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ USADA can grant a Therapeutic Use Exemption (TUE) in compliance with the World Anti- Doping Agency International Standard for TUEs. The TUE application process

More information

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Number: 09.01.02 Effective Date: September 1, 2013 Initial Review Date: February 18, 2013 Most

More information

Clinical Policy Title: Ear tubes (tympanostomy)

Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Number: 1135 Effective Date: January 1, 2015 Initial Review Date: September 17, 2014 Most Recent Review Date: August 1, 2018 Next Review

More information

Clinical Policy Title: Bone growth stimulators for non-healing fractures

Clinical Policy Title: Bone growth stimulators for non-healing fractures Clinical Policy Title: Bone growth stimulators for non-healing fractures Clinical Policy Number: 14.02.03 Effective Date: January 1, 2015 Initial Review Date: July 16, 2014 Most Recent Review Date: March

More information

National Diabetes Prevention Program Centers for Medicare & Medicaid Service Expansion. Tribal Leaders Diabetes Committee September 22, 2016

National Diabetes Prevention Program Centers for Medicare & Medicaid Service Expansion. Tribal Leaders Diabetes Committee September 22, 2016 National Diabetes Prevention Program Centers for Medicare & Medicaid Service Expansion Tribal Leaders Diabetes Committee September 22, 2016 National Diabetes Prevention Program (DPP) Lifestyle change program

More information

Diabetic Equipment and Supplies

Diabetic Equipment and Supplies Diabetic Equipment and Supplies Chapter.1 Enrollment..................................................................... -2.2 Benefits, Limitations, and Authorization Requirements...........................

More information

2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members

2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members 2017 Diabetes Program Evaluation Our mission is to improve the health and quality of life of our members Diabetes Program Evaluation Program Title: Diabetes Program Evaluation Period: January 1, 2017 December

More information

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Standards of Care in Diabetes 2016-- What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Terminology No longer using the term diabetic. Diabetes does not define people. People

More information

Corporate Medical Policy Investigational (Experimental) Services

Corporate Medical Policy Investigational (Experimental) Services Corporate Medical Policy Investigational (Experimental) Services File Name: Origination: investigational_(experimental)_services 1/1996 Description of Procedure or Service BCBSNC defines the terms "investigational"

More information